CRISPRベースの診断薬の世界市場レポート 2025年

CRISPRベースの診断薬市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR17.9％で99億2,000万米ドルに成長します。予測期間中に予測される成長は、迅速で正確な診断に対する需要の増加、感染症検出における用途の拡大、政府・機関からの資金提供の増加、抗生物質耐性の検出の改善、CRISPR技術に対する認識と受容の高まりといった要因に起因しています。この期間に予想される主な動向には、ポイントオブケア（POC）検査、CRISPR-Cas12およびCas13システムの使用、個別化医療および遺伝子スクリーニングの主な発展、ナノテクノロジーおよびバイオセンサーとの統合、CRISPRベースの早期疾患検出法の開発などがあります。

感染症の罹患率の増加は、CRISPRベースの診断薬市場の拡大を促進すると予想されます。感染症は、細菌、ウイルス、真菌、寄生虫などの病原性微生物によって引き起こされ、人から人へ、または汚染された表面、食品、水、昆虫などの媒介物を通じて広がる可能性があります。これらの疾病の発生頻度の増加は、世界化、抗生物質耐性、気候変動、都市化、人口増加、生息地の破壊、ヘルスケアへのアクセス制限などの要因によるものです。CRISPRベースの診断薬は、迅速かつ正確な病原体の検出、早期診断、迅速な介入、効果的な封じ込め戦略の実現により、感染症との闘いを支援します。例えば、2024年8月、英国の行政機関であるUK Health Security Agency（UKHSA）のデータから、2023年にイングランドで368件の麻疹患者が報告されたことが明らかになりました。これは2022年の53件から7倍近く増加したことになり、ウェスト・ミッドランズが44％、ロンドンが33％を占めました。その結果、感染症の発生率の増加がCRISPRベースの診断薬市場の成長を牽引しています。

CRISPRベースの診断薬市場の主要企業は、CRISPRベースのポイントオブケア検査を通じて迅速で正確な診断へのアクセスを改善するために、戦略的パートナーシップを結ぶことが増えています。戦略的パートナーシップには、共通の目標を達成し、競争力を強化するために、リソースや専門知識を結集する組織間の長期的な協力関係が含まれます。例えば、2023年8月、インドを拠点とするバイオテクノロジー企業CrisprBits Private Limitedは、インドの分子診断会社Molbio Diagnosticsと戦略的提携を結びました。この提携は、病原体や遺伝子マーカーを検出するための、迅速、正確、かつ費用対効果の高い診断ソリューションを提供するCRISPRベースのPOCT（ポイント・オブ・ケア・テスト）の開発に焦点を当てています。その目的は、迅速かつ正確な病気の検出を保証しながら、資源が限られた地域を含む様々な環境における診断の利便性を高めることです。CrisprBitsのCRISPRプラットフォームの専門知識とモルビオの製造・販売能力を組み合わせることで、この提携はこれらの検査を世界市場に導入することを目指しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界CRISPRベースの診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のCRISPRベースの診断薬市場：成長率分析
• 世界のCRISPRベースの診断薬市場の実績：規模と成長, 2019-2024
• 世界のCRISPRベースの診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界CRISPRベースの診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のCRISPRベースの診断薬市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キット
• 緩衝液
• ソフトウェア
• その他の製品
• 世界のCRISPRベースの診断薬市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• リコンビナーゼポリメラーゼ増幅（RPA）
• ループ介在等温増幅（LAMP）
• その他のテクニック
• 世界のCRISPRベースの診断薬市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 非感染性疾患
• 世界のCRISPRベースの診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• バイオテクノロジー企業
• 学術研究機関
• その他のエンドユーザー
• 世界のCRISPRベースの診断薬市場キットの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPR検出キット
• CRISPR増幅キット
• CRISPRベースのアッセイキット
• 世界のCRISPRベースの診断薬市場緩衝液の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPR反応バッファー
• CRISPR溶解バッファー
• 世界のCRISPRベースの診断薬市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPRデータ解析ソフトウェア
• CRISPR設計ソフトウェア
• CRISPR診断プラットフォームソフトウェア
• 世界のCRISPRベースの診断薬市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CRISPR酵素
• CRISPR試薬
• CRISPRベースのプローブ

第7章 地域別・国別分析

• 世界のCRISPRベースの診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のCRISPRベースの診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• CRISPRベースの診断薬市場：競合情勢
• CRISPRベースの診断薬市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Molbio Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • Horizon Discovery Overview, Products and Services, Strategy and Financial Analysis
  • Beam Therapeutics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Intellia Therapeutics Inc.
• Synthego Corporation
• Caribou Biosciences
• Mammoth Biosciences
• Verve Therapeutics
• Editas Medicine
• Epic Bio
• Sherlock Biosciences
• Addgene
• VedaBio
• CrisprBits
• SNIPR BIOME ApS
• TOLO Biotech
• Intact Genomics
• Agdia Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• CRISPRベースの診断薬市場2029：新たな機会を提供する国
• CRISPRベースの診断薬市場2029：新たな機会を提供するセグメント
• CRISPRベースの診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

CRISPR-based diagnostics refers to advanced molecular tools that utilize the CRISPR-Cas system to detect specific nucleic acid sequences with high precision and speed, enabling the identification of diseases or genetic markers. This technology offers groundbreaking capabilities in medical and genomic analysis. CRISPR-based diagnostics are used in applications such as detecting infectious diseases, identifying genetic disorders, and monitoring mutations in cancer research and treatment. It also holds significant potential in personalized medicine and point-of-care testing.

The primary products in CRISPR-based diagnostics include kits, buffer solutions, software, and other components. CRISPR diagnostic kits are ready-to-use tools designed for the rapid and accurate detection of specific genetic material, frequently applied in disease diagnosis and research. Techniques used in this process include recombinase polymerase amplification (RPA), loop-mediated isothermal amplification (LAMP), and others. These diagnostics are used for both infectious and non-infectious diseases and are employed by hospitals, diagnostic centers, biotechnology companies, academic and research institutions, among others.

The CRISPR-based diagnostics market research report is one of a series of new reports from The Business Research Company that provides CRISPR-based diagnostics market statistics, including CRISPR-based diagnostics industry global market size, regional shares, competitors with CRISPR-based diagnostics market share, detailed CRISPR-based diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the CRISPR-based diagnostics industry. This CRISPR-based diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The CRISPR-based diagnostics market size has grown rapidly in recent years. It will grow from $4.35 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 18.1%. The growth observed during the historic period can be attributed to factors such as an increase in healthcare expenditure, a rising demand for gene editing, a higher prevalence and incidence of chronic diseases, growing awareness of available treatments, and a rise in the prevalence of genetic disorders.

The CRISPR-based diagnostics market size is expected to see rapid growth in the next few years. It will grow to $9.92 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth projected for the forecast period can be attributed to factors such as the increasing demand for rapid and accurate diagnostics, expanding applications in infectious disease detection, rising government and institutional funding, improved detection of antibiotic resistance, and growing awareness and acceptance of CRISPR technologies. Key trends anticipated during this period include point-of-care (POC) testing, the use of CRISPR-Cas12 and Cas13 systems, advancements in personalized medicine and genetic screening, integration with nanotechnology and biosensors, and the development of CRISPR-based early disease detection methods.

The growing incidence of infectious diseases is expected to drive the expansion of the CRISPR-based diagnostics market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, which can spread from person to person or through contaminated surfaces, food, water, or vectors such as insects. The rising frequency of these diseases is attributed to factors including globalization, antibiotic resistance, climate change, urbanization, population growth, habitat destruction, and limited access to healthcare. CRISPR-based diagnostics support the fight against infectious diseases by offering rapid and accurate pathogen detection, enabling early diagnosis, prompt intervention, and effective containment strategies. For example, in August 2024, data from the UK Health Security Agency (UKHSA), a UK-based executive agency, revealed that 368 measles cases were reported in England in 2023. This represented a nearly sevenfold increase from the 53 cases in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. As a result, the increasing incidence of infectious diseases is driving the growth of the CRISPR-based diagnostics market.

Major players in the CRISPR-based diagnostics market are increasingly forming strategic partnerships to improve access to rapid and accurate diagnostics through CRISPR-based point-of-care tests. A strategic partnership involves a long-term collaboration between organizations that combine their resources and expertise to achieve shared goals and strengthen their competitive edge. For example, in August 2023, CrisprBits Private Limited, a biotechnology company based in India, entered into a strategic collaboration with Molbio Diagnostics, an Indian molecular diagnostics company. This partnership focuses on developing CRISPR-based point-of-care tests (POCTs) that offer rapid, precise, and cost-effective diagnostic solutions for detecting pathogens and genetic markers. The goal is to enhance diagnostic accessibility in various environments, including resource-limited areas, while ensuring quick and accurate disease detection. By combining CrisprBits' CRISPR platform expertise with Molbio's manufacturing and distribution capabilities, the collaboration aims to introduce these tests to a global market.

In February 2024, Ginkgo Bioworks Holdings Inc., a biotechnology company based in the United States, acquired Proof Diagnostics Inc. for an undisclosed amount. The acquisition is intended to enhance Ginkgo's gene therapy services by incorporating Proof Diagnostics' OMEGA RNA-programmable nuclease technology, thereby improving its gene editing capabilities. This strategic move strengthens Ginkgo's ability to offer advanced solutions in therapeutic development and precision gene editing. Proof Diagnostics Inc. is a US-based company that specializes in CRISPR-based molecular testing solutions for COVID-19.

Major players in the crispr-based diagnostics market are Thermo Fisher Scientific Inc., Integrated DNA Technologies Inc., Molbio Diagnostics, Horizon Discovery, Beam Therapeutics, Intellia Therapeutics Inc., Synthego Corporation, Caribou Biosciences, Mammoth Biosciences, Verve Therapeutics, Editas Medicine, Epic Bio, Sherlock Biosciences, Addgene, VedaBio, CrisprBits, SNIPR BIOME ApS, TOLO Biotech, Intact Genomics, Agdia Inc., and ToolGen Inc.

North America was the largest region in the CRISPR-based diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in CRISPR-based diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the CRISPR-based diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The CRISPR-based diagnostics market includes revenues earned by entities by providing services such as diagnostic testing services, custom CRISPR assays development, screening and surveillance services, and regulatory and compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The CRISPR-based diagnostics market also consists of sales of CRISPR-based RNA detection systems, CRISPR-based monitoring tools, lateral flow assays, and CRISPR-based test platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

CRISPR-Based Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crispr-based diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crispr-based diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crispr-based diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Kits; Buffer Solutions; Software; Other Products
• 2) By Technique: Recombinase Polymerase Amplification (RPA); Loop-mediated Isothermal Amplification (LAMP); Other Techniques
• 3) By Disease: Infectious Diseases; Non-Infectious Diseases
• 4) By End-User: Hospitals; Diagnostic Centers; Biotechnology Companies; Academic And Research Institutes; Other End-Users
• Subsegments:
• 1) By Kits: CRISPR Detection Kits; CRISPR Amplification Kits; CRISPR-Based Assay Kits
• 2) By Buffer Solutions: CRISPR Reaction Buffers; CRISPR Lysis Buffers
• 3) By Software: CRISPR Data Analysis Software; CRISPR Design Software; CRISPR Diagnostic Platforms Software
• 4) By Other Products: CRISPR Enzymes; CRISPR Reagents; CRISPR-Based Probes
• Companies Mentioned: Thermo Fisher Scientific Inc.; Integrated DNA Technologies Inc.; Molbio Diagnostics; Horizon Discovery; Beam Therapeutics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. CRISPR-Based Diagnostics Market Characteristics

3. CRISPR-Based Diagnostics Market Trends And Strategies

4. CRISPR-Based Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global CRISPR-Based Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global CRISPR-Based Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global CRISPR-Based Diagnostics Market Growth Rate Analysis
• 5.4. Global CRISPR-Based Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global CRISPR-Based Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global CRISPR-Based Diagnostics Total Addressable Market (TAM)

6. CRISPR-Based Diagnostics Market Segmentation

• 6.1. Global CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Buffer Solutions
• Software
• Other Products
• 6.2. Global CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinase Polymerase Amplification (RPA)
• Loop-mediated Isothermal Amplification (LAMP)
• Other Techniques
• 6.3. Global CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Non-Infectious Diseases
• 6.4. Global CRISPR-Based Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Biotechnology Companies
• Academic And Research Institutes
• Other End-Users
• 6.5. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Detection Kits
• CRISPR Amplification Kits
• CRISPR-Based Assay Kits
• 6.6. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Buffer Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Reaction Buffers
• CRISPR Lysis Buffers
• 6.7. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Data Analysis Software
• CRISPR Design Software
• CRISPR Diagnostic Platforms Software
• 6.8. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRISPR Enzymes
• CRISPR Reagents
• CRISPR-Based Probes

7. CRISPR-Based Diagnostics Market Regional And Country Analysis

• 7.1. Global CRISPR-Based Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global CRISPR-Based Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific CRISPR-Based Diagnostics Market

• 8.1. Asia-Pacific CRISPR-Based Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China CRISPR-Based Diagnostics Market

• 9.1. China CRISPR-Based Diagnostics Market Overview
• 9.2. China CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India CRISPR-Based Diagnostics Market

• 10.1. India CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan CRISPR-Based Diagnostics Market

• 11.1. Japan CRISPR-Based Diagnostics Market Overview
• 11.2. Japan CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia CRISPR-Based Diagnostics Market

• 12.1. Australia CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia CRISPR-Based Diagnostics Market

• 13.1. Indonesia CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea CRISPR-Based Diagnostics Market

• 14.1. South Korea CRISPR-Based Diagnostics Market Overview
• 14.2. South Korea CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe CRISPR-Based Diagnostics Market

• 15.1. Western Europe CRISPR-Based Diagnostics Market Overview
• 15.2. Western Europe CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK CRISPR-Based Diagnostics Market

• 16.1. UK CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany CRISPR-Based Diagnostics Market

• 17.1. Germany CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France CRISPR-Based Diagnostics Market

• 18.1. France CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy CRISPR-Based Diagnostics Market

• 19.1. Italy CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain CRISPR-Based Diagnostics Market

• 20.1. Spain CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe CRISPR-Based Diagnostics Market

• 21.1. Eastern Europe CRISPR-Based Diagnostics Market Overview
• 21.2. Eastern Europe CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia CRISPR-Based Diagnostics Market

• 22.1. Russia CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America CRISPR-Based Diagnostics Market

• 23.1. North America CRISPR-Based Diagnostics Market Overview
• 23.2. North America CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA CRISPR-Based Diagnostics Market

• 24.1. USA CRISPR-Based Diagnostics Market Overview
• 24.2. USA CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada CRISPR-Based Diagnostics Market

• 25.1. Canada CRISPR-Based Diagnostics Market Overview
• 25.2. Canada CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America CRISPR-Based Diagnostics Market

• 26.1. South America CRISPR-Based Diagnostics Market Overview
• 26.2. South America CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil CRISPR-Based Diagnostics Market

• 27.1. Brazil CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East CRISPR-Based Diagnostics Market

• 28.1. Middle East CRISPR-Based Diagnostics Market Overview
• 28.2. Middle East CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa CRISPR-Based Diagnostics Market

• 29.1. Africa CRISPR-Based Diagnostics Market Overview
• 29.2. Africa CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. CRISPR-Based Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. CRISPR-Based Diagnostics Market Competitive Landscape
• 30.2. CRISPR-Based Diagnostics Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Molbio Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Horizon Discovery Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Beam Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. CRISPR-Based Diagnostics Market Other Major And Innovative Companies

• 31.1. Intellia Therapeutics Inc.
• 31.2. Synthego Corporation
• 31.3. Caribou Biosciences
• 31.4. Mammoth Biosciences
• 31.5. Verve Therapeutics
• 31.6. Editas Medicine
• 31.7. Epic Bio
• 31.8. Sherlock Biosciences
• 31.9. Addgene
• 31.10. VedaBio
• 31.11. CrisprBits
• 31.12. SNIPR BIOME ApS
• 31.13. TOLO Biotech
• 31.14. Intact Genomics
• 31.15. Agdia Inc.

32. Global CRISPR-Based Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The CRISPR-Based Diagnostics Market

34. Recent Developments In The CRISPR-Based Diagnostics Market

35. CRISPR-Based Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 CRISPR-Based Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 CRISPR-Based Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 CRISPR-Based Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer